Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLENZ THERAPEUTICS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

LENZ THERAPEUTICS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
    Aug 11, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
    Aug 4, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia
    Jul 6, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
    Jun 24, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
    Jun 7, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics to Participate in Upcoming Investor Conferences
    May 26, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
    May 11, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference
    May 4, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
    Apr 20, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
    Mar 24, 2026LENZ Therapeutics, Inc. (LENZ) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$4.13Close · Sep 22, 2026